Cancer · Austria
Acute myeloid leukaemia
How is it diagnosed today? Your family doctor usually arranges an urgent blood test, and may send you to a hospital specialist or straight to hospital. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.13 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Intensive chemo, sometimes a stem cell transplant. NHS
15 medicines are approved for this disease in Austria:
Show all 15
- Arsenic trioxide (Trisenox, Arsenic trioxide Accord, Arsenic trioxide medac) – approved in 2002
- Azacitidine (Onureg, Azacitidine Mylan, Azacitidine Kabi) – approved in 2008
- Cedazuridine and decitabine (Inaqovi, Inqovi) – approved in 2023
- Daunorubicin and cytarabine (Vyxeos liposomal, Vyxeos) – approved in 2018
- Decitabine (Dacogen, Decitabin Sandoz) – approved in 2012
- Gemtuzumab ozogamicin (Mylotarg) – approved in 2018
- Gilteritinib (Xospata) – approved in 2019
- Glasdegib (Daurismo) – approved in 2020
- Histamine dihydrochloride (Ceplene) – approved in 2008
- Ivosidenib (Tibsovo) – approved in 2023
- Melphalan (Phelinun) – approved in 2020
- Midostaurin (Rydapt) – approved in 2017
- Quizartinib (Vanflyta) – approved in 2023
- Venetoclax (Venclyxto, Venclexta) – approved in 2016
- Posaconazole (Noxafil, Posaconazole Accord, Posaconazole AHCL) – approved in 2005
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (17)
- Cyclophosphamide (Frindovyx) – approved for it in the US
- Cytarabine (Cytarabine, Aracytine, Cytarabine Sandoz) – approved for it in the US and France
- Daunorubicin (Daunorubicin Hydrochloride, Daunoblastin, Cerubidine) – approved for it in the US, Switzerland, and France
- Doxorubicin (Doxorubicin Hydrochloride) – approved for it in the US
- Enasidenib (Idhifa) – approved for it in the US
- Etoposide (Celltop, Etopophos) – approved for it in France
- Filgrastim (Neupogen) – approved for it in the US
- Idarubicin (Zavedos, Idamycin PFS, Idarubicine Accord) – approved for it in the US and France
- Mercaptopurine (Purinethol) – approved for it in France
- Mitoxantrone (mitoXANTRONE) – approved for it in the US
- Olutasidenib (Rezlidhia) – approved for it in the US
- Revumenib (Revuforj) – approved for it in the US
- Sargramostim (Leukine) – approved for it in the US
- Thioguanine (Tabloid, Lanvis) – approved for it in the US and France
- Treosulfan (Grafapex) – approved for it in the US
- Tretinoin (Tretinoin, Vesanoid) – approved for it in the US, Switzerland, and France
- Ziftomenib (Komzifti) – approved for it in the US
Being tested in people
13 open trials in Austria, 628 worldwide. See the trials
- 4 chemotherapy blocks: Course 1 AIE (cytarabine/idarubicin/etoposide), Course 2 AI (cytarabine/idarubicin), Course 3 HAD (high-dose cytarabine (1g)/daunorubicin), Course 4 HA (high-dose cytarabine). (Phase 3)
- AG-120 (Phase 3)
- AG-221 (Phase 3)
- all-trans retinoic acid (ATRA) (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 2 were in animals and 0 in the lab. See them
No proof it works
Animal worm medicines (ivermectin, fenbendazole) for cancer: not approved, and not enough research in people to know if they help. American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
13 open trials in Austria, and 1 opening soon or by invitation
Tests venetoclax with chemotherapy for newly diagnosed acute myeloid leukemia
NCT04628026 · ClinicalTrials.gov
- Innsbruck – Tirol Kliniken GmbH
- Linz – Kepler Universitaetsklinikum GmbH
- Linz – Ordensklinikum Linz GmbH
- and 3 more sites
Ages 18 to 75
Contact the trial teamTests bleximenib with chemotherapy in newly diagnosed acute myeloid leukemia
NCT07223814 · ClinicalTrials.gov
- Linz – Ordensklinikum Linz GmbH
- Vienna – Hanusch Krankenhaus der Wiener Gebietskrankenkasse
Age 18 and over
Contact the trial teamTests bleximenib with venetoclax and azacitidine for newly diagnosed acute myeloid leukemia
NCT06852222 · ClinicalTrials.gov
- Linz – Kepler Universitatsklinikum GmbH
- Linz – Ordensklinikum Linz GmbH Elisabethinen
- Salzburg – Universitaetsklinikum Salzburg Landeskrankenhaus
- and 3 more sites
Age 18 and over
Contact the trial teamPivekimab sunirine added to venetoclax and azacitidine for newly diagnosed acute myeloid leukemia
NCT07581002 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Linz – Ordensklinikum Linz GmbH
- Vienna – Medical University of Vienna
- and 1 more site
Age 18 and over
Contact the trial teamTests revumenib with chemotherapy for newly diagnosed acute myeloid leukemia with NPM1 mutation
NCT07211958 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Linz – Ordensklinikum Linz GmbH
- and 1 more site
Age 12 and over
Contact the trial teamTests venetoclax added to ivosidenib and azacitidine for acute myeloid leukemia
2024-512753-24-00 · EU Clinical Trials Register
- Innsbruck – Medizinische Universitaet Innsbruck
- Salzburg – SCRI CCCIT Ges.m.b.H.
- Vienna – Hanusch Krankenhaus der Wiener Gebietskrankenkasse
Age 18 and over
Contact the trial teamTests ziftomenib with chemotherapy in children with relapsed acute leukemia
NCT06376162 · ClinicalTrials.gov
- Vienna – St. Anna Kinderspital GmbH
Ages 0 to 21
Contact the trial teamTests bezuclastinib in adults with advanced systemic mastocytosis
NCT04996875 · ClinicalTrials.gov
- Vienna – AKH Wien, Universitatsklinikum
Age 18 and over
Contact the trial teamAdding revumenib to standard treatment for newly diagnosed acute myeloid leukemia
NCT06652438 · ClinicalTrials.gov
- Linz – Kepler Universitaetsklinikum GmbH
- Salzburg – SCRI CCCIT Ges.m.b.H.
- Vienna – Hanusch Krankenhaus der Wiener Gebietskrankenkasse
Age 18 and over
Contact the trial teamRevumenib plus chemotherapy for children with relapsed or resistant acute myeloid leukemia
2025-521390-14-00 · EU Clinical Trials Register
- Vienna – St. Anna Kinderspital GmbH
Up to age 64
Contact the trial teamContinued ASTX727 treatment for people from earlier studies with blood cancers
NCT04093570 · ClinicalTrials.gov
- Vienna – Klinik Hietzing
Age 18 and over
Contact the trial teamTests ivosidenib with azacitidine in adults with a leukemia gene mutation
NCT05907057 · ClinicalTrials.gov
- Linz – Ordensklinikum Linz GmbH
- Vienna – Medical University of Vienna
- Wels – Klinikum Wels-Grieskirchen GmbH
Age 18 and over
Contact the trial teamRegistry study following adults with acute myeloid leukemia and related blood cancers
NCT01252485 · ClinicalTrials.gov
- Graz – Medizinische Universität Graz
- Innsbruck – Medizinische Universität Innsbruck
- Linz – Krankenhaus der Elisabethinen Linz GmbH
- and 5 more sites
Age 18 and over
Contact the trial teamAdding venetoclax to standard treatment for IDH1-mutated acute myeloid leukemia
NCT07075016 · ClinicalTrials.gov
- Feldkirch – AT-Feldkirch-IKHF
- Salzburg – AT-Salzburg-SALK
- Vienna – AT-Vienna-HANUSCH
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Available abroad (742 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests ponatinib in children with hard-to-treat leukemias, lymphomas or solid tumors
NCT03934372 · ClinicalTrials.gov
Countries: Belgium, Spain, France and 4 more
- Ghent, Belgium – Ghent university hospital
- Barcelona, Spain – Hospital General Universitario Vall D Hebron
- Barcelona, Spain – Hospital Sant Joan de Deu de Manresa
Ages 1 to 17
Contact the trial teamAdding quizartinib to venetoclax and azacitidine for older adults with acute myeloid leukemia
NCT07478991 · ClinicalTrials.gov
Countries: Spain
- Albacete, Spain – Complejo Hospitalario de Albacete
- Alcalá de Henares, Spain – Hospital Principe de Asturias
- Alicante, Spain – Hospital General Universitario Dr. Balmis
Age 18 and over
Contact the trial teamTests ziftomenib with standard drugs for untreated AML with certain gene changes
NCT07007312 · ClinicalTrials.gov
Countries: Belgium, Czechia, Germany and 14 more
- Jette, Belgium – UZ Brussel
- Liège, Belgium – Centre Hospitalier Universitaire de Liège
- Roeselare, Belgium – Algemeen Ziekenhuis Delta
Age 18 and over
Contact the trial teamComparing two drugs to prevent graft-versus-host disease after stem cell transplant in older patients
2023-504555-27-00 · EU Clinical Trials Register
Countries: France
- Angers, France – Centre Hospitalier Universitaire D'Angers
- Clermont-Ferrand, France – University Hospital Of Clermont-Ferrand
- Lille, France – Centre Hospitalier Universitaire de Lille
Age 18 and over
Contact the trial teamStudy of how the body absorbs ziftomenib in relapsed or hard-to-treat AML or MDS
NCT07929740 · ClinicalTrials.gov
Countries: Spain, France, Italy
- Barcelona, Spain – Hospital Clinic de Barcelona
- Madrid, Spain – MD Anderson Cancer Center
- Oviedo, Spain – Hospital Universitario Central De Asturias
Age 18 and over
Contact the trial teamVaccine Tested in Adults with Acute Myeloid Leukemia in Remission
NCT06252584 · ClinicalTrials.gov
Countries: Germany
- Tübingen, Germany – University Hospital Tuebingen
Age 18 and over
Contact the trial teamTesting CHM-029 pill in adults with relapsed or hard-to-treat acute myeloid leukemia
NCT07751991 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 3 more
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
- Cáceres, Spain – Hospital San Pedro De Alcántara
- Madrid, Spain – Hospital Universitario Fundación Jiménez Díaz
Age 18 and over
Contact the trial teamTesting JNJ-95804306 in Blood Cancers That Returned or Did Not Respond to Treatment
2026-525234-39-00 · EU Clinical Trials Register
Countries: Belgium, Germany, Denmark and 2 more
- Edegem, Belgium – Universitair Ziekenhuis Antwerpen
- Leuven, Belgium – UZ Leuven
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
No age limit given in the registry
Contact the trial teamTests the safety of CCS1477 in adults with advanced blood cancers
2024-519498-20-00 · EU Clinical Trials Register
Countries: Spain
- Badalona, Spain – Institut Catala d'Oncologia
- Barcelona, Spain – Hospital Clinic de Barcelona
- L'Hospitalet de Llobregat, Spain – Institut Catala D'oncologia
Age 18 and over
Contact the trial teamContinued Treatment and Safety Monitoring for People With Certain Cancers
NCT06788509 · ClinicalTrials.gov
Countries: Denmark, Spain, France and 11 more
- Odense C, Denmark – Odense University Hospital
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Barcelona, Spain – Hospital Clinic de Barcelona
Age 18 and over
Contact the trial teamFirst test of GEN3018 in adults with returned or resistant acute myeloid leukemia
NCT07384715 · ClinicalTrials.gov
Countries: Spain, Italy, Netherlands
- Barcelona, Spain – Hospital Clinic de Barcelona
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Madrid, Spain – Hospital Universitario 12 de Octubre
Age 18 and over
Contact the trial teamGene-guided cladribine drug combinations for acute myeloid leukemia
2023-503394-37-00 · EU Clinical Trials Register
Countries: Poland
- Bialystok, Poland – Uniwersytecki Szpital Kliniczny w Bialymstoku
- Brzozów, Poland – Szpital Specjalistyczny W Brzozowie Podkarpacki Osrodek Onkologiczny Im.Ks.B.Markiewicza
- Bydgoszcz, Poland – Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy
Age 18 and over
Contact the trial teamTests a structured exercise program for adults with blood cancers
NCT07912684 · ClinicalTrials.gov
Countries: Italy
- Bari, Italy – Irccs Oncologico Istituto Tumori Giovanni Paolo Ii - Bari - Uo Ematologia
- Roma, Italy – Fondazione PTV - POLICLINICO TOR VERGATA
- Verona, Italy – Aou Integrata Di Verona, Policlinico G.B. Rossi - Uoc Ematologia
Ages 18 to 75
Contact the trial teamAMX-883 for acute myeloid leukaemia and high-risk myelodysplastic syndrome
NCT07723703 · ClinicalTrials.gov
Countries: United Kingdom, United States
- Manchester, United Kingdom – The Christie NHS Foundation Trust - Christie Hospital
- Fairfax, United States – NEXT Oncology- Virginia
- New York, United States – Memorial Sloan-Kettering Cancer Center - Hematology Service MSKCC
Age 18 and over
Contact the trial teamTests mocravimod with stem cell transplant for acute myeloid leukemia
NCT05429632 · ClinicalTrials.gov
Countries: Switzerland, Germany, Spain and 11 more
- Basel, Switzerland – Universitaetsspital Basel
- Freiburg im Breisgau, Germany – Universitätsklinikum Freiburg
- Halle, Germany – Universitätsklinikum Halle
Ages 18 to 75
Contact the trial teamTesting QTX-2101 with ATRA in adults newly diagnosed with acute promyelocytic leukemia
NCT07504458 · ClinicalTrials.gov
Countries: Spain, France, Italy and 2 more
- Badalona, Spain – Institut Catala d'Oncologia (ICO) Badalona - Hospital Universitari Germans Trias i Pujol
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Barcelona, Spain – Hospital de la Santa Creu i Sant Pau
Ages 18 to 71
Contact the trial teamTests REM-422 in adults with relapsed or hard-to-treat AML or higher-risk MDS
NCT06297941 · ClinicalTrials.gov
Countries: France, United States
- Bordeaux, France – Centre Hospitalier Universitaire (CHU) de Bordeaux
- Paris, France – AP-HP Hôpital Saint Louis
- Toulouse, France – IUCT Oncopôle
Age 18 and over
Contact the trial teamTests APL-4098 alone and with other drugs in adults with blood cancers
NCT06372717 · ClinicalTrials.gov
Countries: United Kingdom, Australia
- Cardiff, United Kingdom – University Hospital of Wales
- Glasgow, United Kingdom – Beatson West of Scotland Cancer Centre
- London, United Kingdom – The Royal Marsden Hospital
Age 18 and over
Contact the trial teamStudies how genes affect azacytidine dosing in blood cancer patients
NCT06886425 · ClinicalTrials.gov
Countries: France
- Marseille, France – Hôpital de la Conception
Age 18 and over
Contact the trial teamCompares intensive and gentler treatments for relapsed acute myeloid leukemia
NCT06713837 · ClinicalTrials.gov
Countries: Czechia, Germany, Spain and 3 more
- Brno, Czechia – Fakultni nemocnice Brno
- Novy Hradec Kralove, Czechia – Fakultni Nemocnice Hradec Kralove
- Olomouc, Czechia – University Hospital Olomouc
Age 18 and over
Contact the trial teamObserves outcomes in people with relapsed or refractory acute myeloid leukemia
NCT06459024 · ClinicalTrials.gov
Countries: Germany, Spain, Italy and 4 more
- Aachen, Germany – University Hospital Aachen
- Greifswald, Germany – University Hospital Greifswald
- Halle, Germany – University Hospital Halle
Age 6 and over
Contact the trial teamAdding quizartinib to venetoclax and azacitidine for newly diagnosed acute myeloid leukemia
2025-522979-29-00 · EU Clinical Trials Register
Countries: Spain
- A Coruña, Spain – Complexo Hospitalario Universitario A Coruña
- Albacete, Spain – Hospital General Universitario de Albacete
- Alcalá de Henares, Spain – Hospital Universitario Principe de Asturias
Age 18 and over
Contact the trial teamMeasuring the CD180 protein on blood cells in acute myeloid leukemia
NCT07895901 · ClinicalTrials.gov
Countries: France
- Strasbourg, France – Laboratoire d'Hématologie Biologique - CHU de Strasbourg - France
Age 1 and over
Contact the trial teamTests AZD3632 alone or with other drugs in advanced blood cancers
NCT07155226 · ClinicalTrials.gov
Countries: Germany, United Kingdom, Italy and 5 more
- Dresden, Germany – Technische Universitaet Dresden
- Frankfurt Am Main, Germany – Goethe University Frankfurt
- Heidelberg, Germany – Universitaetsklinikum Heidelberg AöR
Age 16 and over
Contact the trial teamTreatment guided by leftover leukemia cells in adults with acute myeloid leukemia
2026-525759-96-00 · EU Clinical Trials Register
Countries: France
- Angers, France – Centre Hospitalier Universitaire D'Angers
- Bayonne, France – Centre Hospitalier de la Cote Basque
- Béziers, France – Centre Hospitalier de Béziers
Ages 18 to 64
Contact the trial teamLooking at single cells to find markers of venetoclax response in acute myeloid leukemia
NCT07874100 · ClinicalTrials.gov
Countries: Italy
- Milan, Italy – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Haematology Unit
Age 18 and over
Contact the trial teamTests eganelisib alone and with other drugs in blood cancers
NCT06533761 · ClinicalTrials.gov
Countries: Spain, United States
- Cáceres, Spain – Hospital San Pedro De Alcántara
- Valencia, Spain – Hospital Universitario Y Politecnico La Fe
- Aurora, United States – Anshutz Cancer Pavilion
Age 18 and over
Contact the trial teamEarlier stronger treatment for FLT3 acute myeloid leukemia guided by blood tests
NCT04174612 · ClinicalTrials.gov
Countries: Italy
- Bari, Italy – Istituto Tumori Bari Giovanni Paolo II
- Bari, Italy – University Hospital Consorziale Policlinico
- Bologna, Italy – Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Age 18 and over
Contact the trial teamTesting AUTX-703 in adults with relapsed or hard-to-treat leukemia or myelodysplastic syndromes
NCT06846606 · ClinicalTrials.gov
Countries: France, United States
- Villejuif, France – Institut Gustave Roussy
- Buffalo, United States – Roswell Park Comprehensive Cancer Center
- Chapel Hill, United States – University of North Carolina at Chapel Hill
Age 18 and over
Contact the trial teamCAR-cell infusion for leukemia and BPDCN that returned or did not respond
NCT07877610 · ClinicalTrials.gov
Countries: Italy
- Bergamo, Italy – Asst Papa Giovanni XXIII
- Monza, Italy – Fondazione IRCCS San Gerardo dei Tintori
Ages 0 to 75
Contact the trial teamTeicoplanin to Prevent Infections in Children with Acute Myeloid Leukemia
2023-506546-23-00 · EU Clinical Trials Register
Countries: Belgium, Denmark, Spain and 1 more
- Leuven, Belgium – UZ Leuven
- Aarhus N, Denmark – Aarhus Universitetshospital
- Alicante, Spain – Hospital General Universitario Dr. Balmis
Up to age 64
Contact the trial teamBlood Test Study to Detect Early Blood Cancers
NCT05735704 · ClinicalTrials.gov
Countries: Czechia, Greece, Lithuania and 1 more
- Olomouc, Czechia – Fakultni nemocnice Olomouc FNOL
- Athens, Greece – National and Kapodistrian University of Athens (NKUA)
- Vilnius, Lithuania – Vilnus University Hospital Santaros Klinikos (VULSK)
Age 18 and over
Contact the trial teamGilteritinib for acute myeloid leukemia with an FLT3-ITD mutation and leftover cancer cells
2025-521875-30-00 · EU Clinical Trials Register
Countries: Greece
- Athens, Greece – Evaggelismos Hospital
- Athens, Greece – Laiko General Hospital of Athens
- Chaïdári, Greece – University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA"
Age 18 and over
Contact the trial teamTests revumenib in people with relapsed or hard-to-treat acute leukemia
NCT04065399 · ClinicalTrials.gov
Countries: Germany, Spain, France and 7 more
- Hamburg, Germany – University Medical Center Hamburg-Eppendorf
- Leipzig, Germany – Universitaet Leipzig
- Mainz, Germany – Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Age 0 and over
Contact the trial teamTests LB-208 in adults whose leukemia or myelodysplastic syndrome returned or resisted treatment
2025-523396-38-00 · EU Clinical Trials Register
Countries: Spain
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Cáceres, Spain – Hospital San Pedro De Alcántara
- Madrid, Spain – Hospital General Universitario Gregorio Marañón
Age 18 and over
Contact the trial teamOnline Symptom Questionnaires for Older Adults With Acute Leukemia
NCT07597590 · ClinicalTrials.gov
Countries: Spain
- Oviedo, Spain – Hospital Universitario Central de Asturias (HUCA)
Age 65 and over
Contact the trial teamTests oral ASTX030 alone or with venetoclax in myeloid blood cancers
NCT04256317 · ClinicalTrials.gov
Countries: Czechia, Germany, Spain and 7 more
- Brno, Czechia – Fakultni nemocnice Brno
- Ostrava, Czechia – Fakultni nemocnice Ostrava
- Prague, Czechia – Fakultni nemocnice Kralovske Vinohrady
Age 18 and over
Contact the trial teamPivekimab sunirine for children with acute myeloid leukemia that returned or did not respond
NCT07306832 · ClinicalTrials.gov
Countries: France, United Kingdom, Italy and 4 more
- Bordeaux, France – Chu Bordeaux - Hopital Pellegrin /ID# 277645
- Paris, France – Hopital Armand Trousseau /ID# 276231
- Cambridge, United Kingdom – Cambridge University Hospital /ID# 277041
Ages 0 to 17
Contact the trial teamComparing two treatment intensities after leukemia or lymphoma shows no remaining disease
2024-512503-39-00 · EU Clinical Trials Register
Countries: Germany, France, Italy and 1 more
- Augsburg, Germany – Universitaetsklinikum Augsburg
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
- Chemnitz, Germany – Klinikum Chemnitz gGmbH
Age 18 and over
Contact the trial teamTests trametinib and gilteritinib in adults with relapsed or hard-to-treat acute leukemia
2024-518301-18-00 · EU Clinical Trials Register
Countries: Poland
- Gdansk, Poland – Uniwersyteckie Centrum Kliniczne
- Warsaw, Poland – Instytut Hematologii I Transfuzjologii
Age 18 and over
Contact the trial team
Showing 40 of 742. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Acute Myeloid Leukemia in a Patient with Fontan Circulation - Case Report.Prog Pediatr Cardiol · 2026-07-10
- Optimizing Reduced-Intensity Conditioning for Older Patients with AML and MDS: A Large-Scale Analysis from the CIBMTR.Blood · 2026-11-12
- Integrated multi-omics reveals methylation-linked biological heterogeneity in intermediate-risk pediatric acute myeloid leukemia.iScience · 2026-11-02
- In peopleLow-dose 10-day decitabine plus venetoclax induced rapid MRD negativity and durable remission in De Novo AML.Ann Hematol · 2026-08-19
- Two Immune States in Ex Vivo Venetoclax-Resistant AML: Antigen- Presentation Silencing versus Checkpoint Exhaustion.Curr Cancer Drug Targets · 2026-11-11
Is it true?
Saw something on social media? Fact-check it now.
Get screened
For family members and people at higher risk: free checks can find some cancers early, before there are symptoms.
There is no routine screening for this cancer. If you have symptoms or a family history, talk to your doctor.
If several people in your family had cancer, ask your GP whether genetic counselling makes sense for you.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichische Krebshilfe
Free, anonymous counselling at regional centres in every federal state, psycho-oncology and emergency financial aid.
Phone: 01 7966450
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (8)
- DKMS
Finds blood stem cell donors worldwide so that people with blood cancer can have a transplant.
- Acute Leukemia Advocates Network (ALAN)
Global network of 69 acute leukaemia patient organisations (hosted by the Swiss Leukemia Patient Advocates Foundation); member list helps patients find a national group.
- European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
- European Reference Networks (European Commission)
The European Commission's 24 expert networks for rare and complex diseases; your doctor can contact them.
- EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
- Workgroup of European Cancer Patient Advocacy Networks
Network of pan-European cancer patient umbrella groups (including the blood cancer networks): joint advocacy, WECAN Academy training for patient advocates, patient experience data courses.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.